在骨关节炎中与抗高血压药物相关的不良事件:基于FAERS数据库的大型现实世界样本的研究
Zijian Guo1, Jingkai Di1, Zhibo Zhang1
1Department of Orthopedic, The Second Hospital of Shanxi Medical University, Taiyuan, China.
Frontiers in pharmacology
|September 17, 2024
概括
ангиотензин受体阻断剂 (ARBs),特别是瓦尔沙坦,显示了骨关节炎不良事件的显著信号. 建议在给患有骨关节炎和高血压的患者开ARB时谨慎使用.
科学领域:
- 药物监督 药物监督 药物监督
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
背景情况:
- 高血压是骨关节炎 (OA) 患者常见的并发症,影响他们的生活质量.
- 有效的高血压管理对OA患者至关重要,但对抗高血压药物对OA影响的现实数据有限.
研究的目的:
- 调查抗高血压药物与骨关节炎相关的不良事件之间的关联.
- 确定特定的药物类别和与OA患者不良反应相关的药物.
主要方法:
- 使用FAERS数据库 (2004-2023) 进行不成比例分析.
- 比例报告比率 (PRRs) 和报告几率比率 (RORs) 评估了药物与关节炎的关联.
- 分析包括五个主要的抗高血压药物类别和按年龄和性别分类的子组分析.
主要成果:
- ангиотензин受体阻断剂 (ARBs) 显示出显著的关节骨炎 (OA) 副作用信号.
- 瓦尔萨坦在分析的ARB中显示出最强烈的OA不良反应信号.
- 骨关节炎信号在18-65岁和65岁以上的年龄组中最为突出,女性对瓦尔萨坦相关的OA AEs的敏感性更高.
结论:
- ARBs,特别是瓦尔沙坦,与严重的骨关节炎不良事件有关.
- 临床医生应谨慎处方ARB,特别是瓦尔沙坦,给患有同时存在的OA和高血压的患者.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
Antihypertensive Drugs: Direct Renin Inhibitors
510
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
510
Pharmacovigilance
788
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
500
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
500
Antihypertensive Drugs: Angiotensin II Receptor Blockers
606
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
606
Antihypertensive Drugs: Potassium-Sparing Diuretics
475
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
475


